Todd Brady

(Dr. Todd Brady M.D. Ph.D.)

Currently holds positions in Evoke Pharma Inc, Outlook Therapeutics Inc and Aldeyra Therapeutics Inc

Positions

Position Company Period
Director Evoke Pharma Inc June 1, 2007 -
Independent Director Outlook Therapeutics Inc Sept. 1, 2014 -
President, Chief Executive Officer, Director Aldeyra Therapeutics Inc Jan. 23, 2012 -
Director Aldeyra Therapeutics Inc Jan. 1, 2005 - Jan. 22, 2012
Todd Brady's trades of Aldeyra Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-12 2024-03-12
S Sale
85,324 -5.5%
3.05
USD 260,238 		85,324 -5.5% 3.05 USD 260,238
2024-03-12 2024-03-11
S Sale
97,914 -5.9%
3.27
USD 320,521 		97,914 -5.9% 3.27 USD 320,521
2022-06-27 2022-06-23
B Purchase
17,700 +1.5%
3.36
USD 59,546 		17,700 +1.5% 3.36 USD 59,546
2019-10-02 2019-09-30
PP Planned purchase
8,710 +1.4%
5.68
USD 49,483 		8,710 +1.4% 5.68 USD 49,483
2019-09-25 2019-09-23
PP Planned purchase
8,680 +1.4%
5.81
USD 50,433 		8,680 +1.4% 5.81 USD 50,433
2019-09-20 2019-09-18
B Purchase
14,288 +2.4%
5.91
USD 84,465 		14,288 +2.4% 5.91 USD 84,465
2019-09-17 2019-09-16
B Purchase
3,000 +0.5%
6.03
USD 18,090 		3,000 +0.5% 6.03 USD 18,090
2019-09-17 2019-09-13
B Purchase
10,000 +1.7%
5.79
USD 57,900 		10,000 +1.7% 5.79 USD 57,900
2019-09-11 2019-09-10
B Purchase
10,000 +1.8%
5.39
USD 53,937 		10,000 +1.8% 5.39 USD 53,937
2019-09-11 2019-09-09
PP Planned purchase
10,000 +1.8%
4.89
USD 48,887 		10,000 +1.8% 4.89 USD 48,887
// ... existing code ... // ... rest of the file ...